Kun Hu1, Frank A J L Scheer, Ruud M Buijs, Steven A Shea. 1. Division of Sleep Medicine, Brigham and Women's Hospital, Harvard Medical School, 221 Longwood Avenue, Boston, MA 02115, USA. khu@bidmc.harvard.edu
Abstract
AIMS: Adverse cardiovascular events in humans occur with a day/night pattern, presumably related to a daily pattern of behaviours or endogenous circadian rhythms in cardiovascular variables. Healthy humans possess a scale-invariant/fractal structure in heartbeat fluctuations that exhibits an endogenous circadian rhythm and changes towards the structure observed in cardiovascular disease at the circadian phase corresponding to the time of the broad peak of adverse cardiovascular events (at about 10 AM). To explore the relationship between the rest/activity cycle, endogenous circadian rhythmicity, and cardiac vulnerability, we tested whether the fractal structure of heart rate exhibits a similar circadian rhythm in a mammalian species that is nocturnally active (Wistar rats) compared with diurnally active humans, and how this fractal structure changes after lesioning the circadian pacemaker (suprachiasmatic nucleus, SCN) in rats. METHODS AND RESULTS: Analysis of heart rate data collected over 10 days in eight intact and six SCN-lesioned Wistar rats during constant darkness revealed that: (i) as with humans, rats exhibit an endogenous circadian rhythm in the scaling exponent characterizing the hourly fractal structure of heart rate (P = 0.0005) with larger exponents during the biological day (inactive phase for rats; active phase for humans); (ii) SCN lesioning abolished the rhythm in the fractal structure of heart rate and systematically increased the scaling exponent (P = 0.01). CONCLUSION: Rats possess a circadian rhythm of fractal structure of heart rate with a similar temporal pattern as previously observed in humans despite opposite rest/activity cycles between the two species. The SCN imparts this endogenous rhythm. Moreover, lesioning the SCN in rats results in a larger scaling exponent, as occurs with cardiovascular disease in humans.
AIMS: Adverse cardiovascular events in humans occur with a day/night pattern, presumably related to a daily pattern of behaviours or endogenous circadian rhythms in cardiovascular variables. Healthy humans possess a scale-invariant/fractal structure in heartbeat fluctuations that exhibits an endogenous circadian rhythm and changes towards the structure observed in cardiovascular disease at the circadian phase corresponding to the time of the broad peak of adverse cardiovascular events (at about 10 AM). To explore the relationship between the rest/activity cycle, endogenous circadian rhythmicity, and cardiac vulnerability, we tested whether the fractal structure of heart rate exhibits a similar circadian rhythm in a mammalian species that is nocturnally active (Wistar rats) compared with diurnally active humans, and how this fractal structure changes after lesioning the circadian pacemaker (suprachiasmatic nucleus, SCN) in rats. METHODS AND RESULTS: Analysis of heart rate data collected over 10 days in eight intact and six SCN-lesioned Wistar rats during constant darkness revealed that: (i) as with humans, rats exhibit an endogenous circadian rhythm in the scaling exponent characterizing the hourly fractal structure of heart rate (P = 0.0005) with larger exponents during the biological day (inactive phase for rats; active phase for humans); (ii) SCN lesioning abolished the rhythm in the fractal structure of heart rate and systematically increased the scaling exponent (P = 0.01). CONCLUSION:Rats possess a circadian rhythm of fractal structure of heart rate with a similar temporal pattern as previously observed in humans despite opposite rest/activity cycles between the two species. The SCN imparts this endogenous rhythm. Moreover, lesioning the SCN in rats results in a larger scaling exponent, as occurs with cardiovascular disease in humans.
Authors: R Furlan; W Crivellaro; S Dell'Orto; E Gentile; S Piazza; M R Pagani; M Tinelli; S Cerutti; F Lombardi; M Pagani Journal: J Hypertens Suppl Date: 1989-12
Authors: Thomas Penzel; Jan W Kantelhardt; Ludger Grote; Jörg-Hermann Peter; Armin Bunde Journal: IEEE Trans Biomed Eng Date: 2003-10 Impact factor: 4.538
Authors: I Kawachi; G A Colditz; M J Stampfer; W C Willett; J E Manson; F E Speizer; C H Hennekens Journal: Circulation Date: 1995-12-01 Impact factor: 29.690
Authors: Changgui Gu; Claudia P Coomans; Kun Hu; Frank A J L Scheer; H Eugene Stanley; Johanna H Meijer Journal: Proc Natl Acad Sci U S A Date: 2015-02-09 Impact factor: 11.205